natgillin/translations-raw huggingface dataset:
Therefore, only the use of specific health communication strategies and techniques can tailor messages to maximize public attention, raise awareness of health risks, contribute to improve health literacy levels, promote solutions and increase the likelihood of adoption of health behaviours and practices. 
Samo z uporabo specifičnih strategij in tehnik obveščanja v zvezi z zdravjem je mogoče sporočila oblikovati na tak način, da pritegnejo kar največ javne pozornosti, povečajo zavedanje o tveganjih za zdravje, prispevajo k izboljšanju zdravstvene pismenosti, spodbujajo rešitve in povečajo verjetnost sprejetja določenega zdravstvenega vedenja in praks.
Regular analysis and evaluation of health communication programs can help to identify strengths and weaknesses of and may indicate when corrective measures are necessary. 
Redne analize in ocene programov obveščanja v zvezi z zdravjem lahko pomagajo pri odkrivanju prednosti in slabosti ter pokažejo, ali so potrebni določeni korektivni ukrepi.
Outbreak communication 
Obveščanje ob izbruhih
Acknowledging that “communication expertise has become as essential to outbreak control as epidemiological training and laboratory analysis”, in 2005 the World Health Organization created Communication Guidelines aiming at clarifying the specific communication challenges faced by public health officials as well as the best practices for communicating with the public during an outbreak of a communicable disease. 
Ob upoštevanju, da je „ strokovno obveščanje za nadzorovanje izbruhov postalo enako pomembno kot usposabljanje na področju epidemiologije in laboratorijske analize “ , je Svetovna zdravstvena organizacija v letu 2005 pripravila Smernice za obveščanje , s katerimi želi pojasniti nekatere komunikacijske izzive, s katerimi se soočajo uradniki za javno zdravje, ter najboljše prakse za komunikacijo z javnostjo v obdobju izbruha nalezljive bolezni.
An effective outbreak communication is one of the tools that can help achieve the public health goal of bringing an outbreak under control as quickly as possible, with as little social disruption as possible. 
Učinkovita komunikacija v obdobju izbruha je eno od orodij, ki lahko pripomore k doseganju javnozdravstvenega cilja čim prejšnjega obvladovanja izbruha s čim manj družbenimi motnjami.
The guidelines identify some fundamental aspects for outbreak communication practice: 
Smernice določajo nekatere temeljne vidike prakse obveščanja v primeru izbruha:
Trust; 
zaupanje,
Announcing early; 
zgodnje obveščanje,
Transparency; 
preglednost,
Understanding the public; 
razumevanje javnosti,
Planning; 
načrtovanje.
Antimicrobial resistance (AMR) 
Odpornost na protimikrobna zdravila
Considering the mechanisms behind the emergence of antimicrobial resistance, the strategy to fight it is rather straightforward: 
Glede na mehanizme, ki delujejo v ozadju pojava odpornosti na protimikrobna zdravila, je strategija boja zoper njo razmeroma jasna:
Use less antibiotics, i.e. only when they are needed to treat patients. 
Uporabljati je treba manj antibiotikov, tj. samo takrat, kadar so resnično potrebni za zdravljenje bolnika.
Prevent the spread of resistant strains between persons. 
Preprečiti je treba širjenje odpornih sevov med ljudmi.
HEALTH TOPICS A-ZREAD MORE ON ECDC SITEIMAGERELATED HEALTH TOPICS 
ZDRAVSTVENE TEME A– Ž PREBERITE VEČ NA STRANI ECDC SLIKA POVEZANE ZDRAVSTVENE TEME
Healthcare-associated infections (HAI) 
Bolnišnične okužbe
The number of deaths occurring as a direct consequence of these infections is estimated to be at least 37 000. 
Zaradi neposrednih posledic teh okužb naj bi letno umrlo vsaj 37 000 ljudi.
The most frequent infections are urinary tract infections, followed by respiratory tract infections, infections after surgery, bloodstream infections, and others (including diarrhoea due to Clostridium difficile). 
Najpogostejše so okužbe sečil, sledijo okužbe dihal, okužbe po operaciji, okužbe krvnega obtoka in drugo (vključno z drisko zaradi Clostridium difficile).
Approximately 20–30% of healthcare-associated infections are considered to be preventable by intensive hygiene and control programmes. 
S programi intenzivne higiene in nadzora bi bilo po ocenah mogoče preprečiti približno 20– 30 % bolnišničnih okužb.
HEALTH TOPICS A-ZREAD MORE ON ECDC SITERELATED HEALTH TOPICSIN THIS SECTIONFEATURED PUBLICATION 
ZDRAVSTVENE TEME A– Ž PREBERITE VEČ NA STRANI ECDC POVEZANE ZDRAVSTVENE TEME V TEM POGLAVJU PREDSTAVLJENE PUBLIKACIJE
Influenza, in swine 
Gripa pri prašičih
Influenza in swine is an acute viral infection of the respiratory tract in pigs, caused by type A influenza virus. 
Gripa pri prašičih je akutna virusna okužba dihal prašičev, ki jo povzroča virus gripe tipa A.
The mortality rate is low in pigs and recovery usually occurs within 7–10 days. 
Stopnja smrtnosti je pri prašičih nizka in prašiči običajno ozdravijo v 7– 10 dneh.
Swine-origin influenza virus infections also occur in wild birds, poultry, horses and humans, but interspecies transmission is considered a rare event. 
Okužba z virusom gripe prašičjega izvora se pojavlja tudi pri divjih pticah, perutnini, konjih in ljudeh, vendar je prenos med vrstami precej redek.
So far three influenza type A virus subtypes have been found in pigs: 
Doslej so pri prašičih odkrili tri podtipe virusa gripe A:
H1N1, H1N2 and H3N2. 
H1N1, H1N2 in H3N2.
Human infections with swine influenza have been detected occasionally since the late 1950s usually in persons with direct exposure to pigs (e.g. people working in pig farms, etc.). 
Okužbe s prašičjo gripo so pri ljudeh občasno zaznavali po letu 1950, običajno pri posameznikih, ki so bili neposredno izpostavljeni prašičem (na primer ljudje, ki delajo na prašičjih farmah ipd.).
In Europe, since 1958 a total of 17 cases have been reported. 
V Evropi so od leta 1958 poročali o skupno 17 primerih.
The 2009 pandemic influenza A(H1N1 ) 
Pandemija gripe A (H1N1) leta 2009
The 2009 pandemic influenza A(H1N1) virus that has been found contains genes from pig, bird and human influenza viruses, in a combination that has never been observed before anywhere in the world. 
V virusu pandemske gripe A (H1N1) iz leta 2009 so odkrili gene virusov prašičje, ptičje in človeške gripe v takšni kombinaciji, kot je pred tem niso opazili še nikjer na svetu.
People become infected with the 2009 pandemic influenza A(H1N1) virus in the same way as for normal seasonal influenza. 
Ljudje se z virusom pandemske gripe A(H1N1) 2009 okužijo na enak način kot z virusom običajne sezonske gripe.
It spreads from person to person via droplets from an infected person who is coughing and sneezing; indirectly when droplets or secretions from the nose and throat settle on objects (including hands) which then are touched by other people who touch their own mouth or nose. 
Med ljudmi se širi s kapljicami okužene osebe, ki kašlja in kiha, posredno pa se širi tudi prek kapljic in izločkov iz nosu in grla, ki ostanejo na določenih predmetih (vključno z rokami) ter se jih nato drugi dotikajo in z dotikom prenašajo v svoja usta ali nos.
Symptoms of the 2009 pandemic influenza A(H1N1) virus in humans are usually similar to regular human seasonal influenza symptoms, involving fever of sudden onset and respiratory symptoms; diarrhoea might also occur. 
Simptomi okužbe z virusom pandemske gripe A(H1N1) 2009 pri ljudeh so običajno podobni simptomom okužbe z navadno sezonsko gripo ter vključujejo nenadno povišanje telesne temperature in težave z dihanjem, pojavi pa se lahko tudi driska.
However, severe complications could occur even in normally healthy persons who become infected with the virus. 
Vendar se tudi pri sicer zdravih posameznikih, ki so okuženi s tem virusom, lahko pojavijo hudi zapleti.
The virus that is now being detected is susceptible to neuraminidase inhibitors but resistant to amantadines. 
Virus, ki ga sedaj odkrivajo, je občutljiv na zaviralce nevrominidaze, vendar odporen na amantadine.
ECDC has recently produced a Definition of terms for the areas affected by the Influenza A(H1N1)v virus . 
ECDC je nedavno oblikoval seznam Opredelitev izrazov za območja, ki jih je prizadel virus gripe A(H1N1)v .
HEALTH TOPICS A-ZREAD MORE ON ECDC SITERELATED HEALTH TOPICSIN SPOTLIGHT 
ZDRAVSTVENE TEME A– Ž PREBERITE VEČ NA STRANI ECDC POVEZANE ZDRAVSTVENE TEME V SREDIŠČU
Influenza pandemic preparedness 
Pripravljenost na pandemijo gripe
At irregular intervals, usually of a few decades, a new influenza virus emerges which is novel to all or most people which means that there can be little specific immunity among humans except for older people who may have met unless they met the same virus. 
V nerednih intervalih, navadno vsakih nekaj desetletij, se pojavi nov virus gripe, ki je za vse ali večino ljudi nov, kar pomeni, da obstaja med ljudmi le majhna specifična imunost, razen pri starejših, ki so se z enakim virusom morda že srečali.
At least some of the three pandemics during the last (20th) century are thought to have come from an animal or bird influenza virus that itself mutated or swapped genes with a human (so called recombination) and acquired the ability to both infect humans and, more importantly, spread between them. 
Prevladuje mnenje, da je vsaj eno izmed treh pandemij v zadnjem (20.) stoletju povzročil virus živalske ali ptičje gripe, ki je mutiral ali zamenjal gene s humano gripo (tako imenovana rekombinacija), s čimer je pridobil sposobnost, da okuži tudi ljudi in, kar je pomembneje, da se širi med njimi.
It is thought that as an animal/bird influenza adapts to humans and becomes transmissible, it also loses some of its pathogenicity for humans. 
Ocenjuje se, da postane živalska/ptičja gripa, potem ko se prilagodi na ljudi in se začne prenašati, manj patogena za ljudi.
This is of evolutionary value as the new strain is more likely to survive if it does not kill its new human host. 
To ima pomembno evolucijsko vrednost, saj je verjetnost preživetja za sev večja, če ne ubije novega človeškega gostitelja.
Eventually as immunity increases among humans, and the pandemic virus changes, the pandemic strain becomes part of (and tends to dominates) the mix of seasonal influenza viruses. 
Ko se naposled med ljudmi poveča imunost in se pandemični virus spremeni, postane pandemični sev del mešanice virusov sezonske gripe (z nagnjenostjo k prevladi).
HEALTH TOPICS A-ZSECTIONSRELATED DOCUMENTSREAD MORE ON ECDC SITEWHAT’S NEWMORE ON THIS TOPICRELATED HEALTH TOPICSIN SPOTLIGHT 
ZDRAVSTVENE TEME A– Ž POGLAVJA POVEZANI DOKUMENTI PREBERITE VEČ NA STRANI ECDC KAJ JE NOVEGA VEČ O TEM POVEZANE ZDRAVSTVENE TEME V SREDIŠČU
Respiratory tract infections 
Okužbe dihal
Avian influenza in humans 
Ptičja gripa pri ljudeh
Influenza is an infectious disease with mostly respiratory characteristics caused by RNA viruses. 
Gripa je infekcijska bolezen s pretežno dihalnimi simptomi, ki jih povzročajo virusi RNA.
The most important causative agent of tuberculosis (TB) is Mycobacterium tuberculosis. M. tuberculosis, together with M. bovis, M. africanum and M. microti, form the ‘M. tuberculosis complex ’, which is a group within the genus Mycobacterium. 
Najpomembnejši povzročitelj tuberkuloze je bakterija Mycobacterium tuberculosis. Ta skupaj z bakterijami M. bovis, M. africanum in M. microti sestavlja „ kompleks M. tuberculosis “ , skupino iz roda Mycobacterium.
Legionnaires’ disease 
Legionarska bolezen
Legionnaires ’ disease is a respiratory disease caused by Legionella. 
Legionarska bolezen je bolezen dihal, ki jo povzroča bakterija Legionella.
Tick-borne relapsing fever 
Ponavljajoča se vročica, ki jo prenašajo klopi
At least six TBRF species are known to occur in Europe or close to its boundaries. 
V Evropi ali njeni bližini je znanih vsaj šest vrst ponavljajočih se vročic, ki jih prenašajo klopi.
The greatest endemic risk in Europe lies in the Iberian peninsula, particularly in the Mediterranean part. 
Največje endemično tveganje v Evropi je na Iberskem polotoku, zlasti na sredozemskem delu.
The disease is characterised by relapsing or recurring episodes of fever, often accompanied by headache, muscle and joint aches and nausea. 
Za bolezen so značilne ponavljajoče se ali recidivne epizode povišane telesne temperature, ki jih pogosto spremljajo glavobol, bolečine v mišicah in sklepih ter slabost.
The number of relapses is highly variable and the interval between fever episodes ranges from four to 14 days. 
Število ponovitev je zelo spremenljivo, obdobja med epizodami povišane telesne temperature pa lahko trajajo od štiri do 14 dni.
Reports of death are rare. 
Poročila o smrtnih primerih so redka.
Recommended measures to prevent infection include avoiding tick-infested areas (especially during summer months), wearing long trousers and tucking trouser legs into socks, using tick repellents, and using bed nets when sleeping on the ground or camping. 
Med priporočenimi ukrepi za preprečevanje okužbe so izogibanje območjem, kjer so prisotni klopi (zlasti v poletnih mesecih), nošenje dolgih hlač in zatikanje hlačnic v nogavice, uporaba zaščitnih sredstev proti klopom in uporaba posteljnih zaščitnih mrež, kadar spimo na tleh, ali pri kampiranju.
Variant Creutzfeldt-Jakob disease (vCJD) 
Variantna Creutzfeldt-Jakobova bolezen
It was first identified in March 1996 in the UK, when 10 cases of a new disease with neurological symptoms were reported and soon associated with the Bovine Spongiform Encephalopathy (BSE), “mad cow ”-disease. 
Prvič je bila odkrita v Združenem kraljestvu marca 1996, ko so poročali o 10 primerih nove bolezni z nevrološkimi simptomi in jo povezali z bovino spongiformno encefalopatijo (BSE), boleznijo „ norih krav “ .
Causative agents of vCJD are prions, composed of misfolded prion proteins (PrPSc), which form aggregates in neurological tissue leading to progressive brain damage and characteristic signs and symptoms of the disease. 
Povzročitelji so prioni, ki so sestavljeni iz napačno zvitih prionskih beljakovin, ki oblikujejo agregate v nevrološkem tkivu ter povzročajo progresivne poškodbe možganov in značilne znake in simptome te bolezni.
Prions are stable and relatively resistant to proteases, high temperatures, UV radiation, and commonly used disinfectants. 
Prioni so stabilni in relativno odporni na proteaze, visoke temperature, UV-sevanje in splošno uporabljena dezinfekcijska sredstva.
Patients with vCJD have prominent psychiatric (frequently depression, anxiety and withdrawal) or sensory symptoms and delayed onset of neurologic abnormalities, including ataxia within weeks or months, and dementia and myoclonus late in the illness. 
Bolniki z variantno Creutzfeldt-Jakobovo bolezen imajo izrazite psihiatrične (pogosto depresija, anksioznost in umik) ali senzorične simptome in odložen nastop nevroloških nepravilnosti, vključno z ataksijo, ki se pojavi v nekaj tednih ali mesecih, ter demenco in mioklonusom v kasnejši fazi bolezni.
The disease always progresses to death. 
Bolezen vedno napreduje do smrti.
Disease duration is 14 months on average. vCJD tends to affect younger individuals, with an average age of onset of around 28 years, compared to sporadic CJD, which tends to affect middle-aged and elderly individuals. 
Bolezen traja povprečno 14 mesecev. Variantna Creutzfeldt Jakobova bolezen običajno prizadene mlajše, pri čemer je povprečna starost ob nastanku bolezni okoli 28 let, v primerjavi s sporadično Creutzfeldt-Jakobovo boleznijo, ki prizadene predvsem ljudi v srednjih letih in starejše posameznike.
The definite diagnosis of vCJD requires post-mortem examination of brain tissue. 
Za dokončno diagnozo variantne Creutzfeldt-Jakobove bolezni je potrebna posmrtna preiskava možganskega tkiva.
The incubation period for vCJD after food borne exposure is thought to be around 10 years. 
Inkubacijska doba za variantno Creutzfeldt-Jakobovo bolezen naj bi bila okoli 10 let po izpostavitvi hrani, ki prenaša okužbo.
No vaccine or treatment is available. 
Na voljo ni nobenega cepiva ali zdravila.
Most reported vCJD cases appear to have been infected through the consumption of bovine meat products contaminated with the agent of BSE. 
Največ primerov okužbe z variantno Creutzfeldt-Jakobovo boleznijo naj bi bilo posledica zaužitja govejega mesa, okuženega z povzročiteljem bovine spongiformne encefalopatije.
In three cases, reported by the UK, the mode of transmission is thought to be through receipt of blood from an asymptomatic, infected donor. 
V treh primerih, o katerih so poročali iz Združenega kraljestva, naj bi bil način prenosa prejem krvi od okuženega darovalca brez simptomov.
Hepatitis C is caused by the hepatitis C virus that was discovered in 1989. 
Hepatitis C povzroča virus hepatitisa C, ki je bil odkrit leta 1989.
Humans are the only reservoir of hepatitis C virus. The infection is mainly acquired through contact through broken skin with infectious blood (often through sharing contaminated equipment among injecting drug users). 
Ljudje so edini rezervoar virusa hepatitisa C. Okužba se v glavnem prenaša ob stiku z okuženo krvjo skozi poškodovano kožo (pogosto z izmenjavanjem okužene opreme med uporabniki drog, ki si drogo injicirajo).
There is a fear that the circulating H5N1 avian influenza viruses may mutate or recombine into a new virus with potential of pandemic spread. 
Obstaja strah, da bi razsajajoči virusi aviarne influence H5N1 mutirali ali se rekombinirali v nov virus z zmožnostjo pandemičnega širjenja.
Brain infection is believed to occur in only one in 10 000 cases, but it often leads to death. 
Do okužbe možganov bi naj prišlo v samo enem izmed 10 000 primerov, vendar pa taka okužba pogosto povzroči smrt.
On the European continent, the last case of paralysis caused by polio was reported from Turkey in November 1998. 
Na evropski celini so o zadnjem primeru paralize, ki jo je povzročil poliovirus, poročali iz Turčije novembra 1998.
In June 2002, the WHO European region was declared polio free. 
Junija 2002 je bila Evropska regija SVO razglašena za območje brez poliovirusa.
Typhoid and paratyphoid fever 
Trebušni tifus in paratifus
Zsuzsanna Jakab was appointed Director of European Centre for Disease Prevention and Control (ECDC) in March 2005. 
Zsuzsanna Jakab je bila za direktorico Evropskega centra za preprečevanje in obvladovanje bolezni (ECDC) imenovana marca 2005.
Before joining the EU, she was Secretary of State in Hungarys Ministry of Health. 
Pred pridružitvijo EU je bila državna sekretarka na madžarskem ministrstvu za zdravje.
In October 2000, Mrs. Jakab was appointed Director of Administration and Management Support in WHO Europe being responsible for the work of the governing bodies of the overall strategic and operational planning, monitoring and evaluation; supervising the work of the WHO Collaborating Centres in Europe; legal matters and administration. 
Oktobra 2000 je bila imenovana za direktorico uprave in podpore vodstvu urada SZO za Evropo ter bila odgovorna za delo organov upravljanja pri splošnem strateškem in operativnem načrtovanju, spremljanju in vrednotenju, nadziranje dela centrov SZO za sodelovanje v Evropi ter pravne zadeve in upravljanje.
In the time between 2002 - 1991, she held several posts including Co-ordinator, Division of Information, Evidence and Communication; Director, Country Health Development; Acting Director, Country Health Development; Co-ordinator, Policy and Country Programme, EUROHEALTH Programme. 
V obdobju od leta 1991 do leta 2002 je bila na več položajih, med drugim je bila koordinatorka v oddelku za informacije, dokaze in komunikacijo, direktorica zdravstvenega razvoja države, izvršna direktorica zdravstvenega razvoja države in koordinatorka programa za politiko in državo v programu EUROHEALTH.
In 2008 a meeting on Epidemic Intelligence and Emergency Operations Centres took place in October, which main objective was to present recent developments carried out in ECDC for threat detection, review ECDC strategy in this area and obtain input from Competent Bodies in order to prepare the 2009 work plan. 
Leta 2008 je bilo srečanje o obveščanju o epidemijah in centrih za nujno pomoč pripravljeno oktobra; glavni cilj tega srečanja je bil predstaviti nedavni razvoj, ki ga je ECDC dosegel pri odkrivanju nevarnosti, pregledati strategijo centra ECDC na tem področju in od pristojnih organov pridobiti podatke za pripravo delovnega načrta za leto 2009.
It included also training on accessing the ECDC threat tracking tool (TTT) and an exploration of the first test version of the Epidemic Intelligence Information System (EPIS). 
Vključevalo je tudi usposabljanje o dostopanju do orodja centra ECDC za sledenje nevarnostim in pregled prve preskusne različice informacijskega sistema za obveščanje o epidemijah (EPIS).
“Brown Lagoon” was the first internal simulation exercise that took place in June 2007. 
Simulacijska vaja „Brown Lagoon“ je bila prva notranja simulacijska vaja, potekala pa je junija 2007.
It was designed to provide ECDC with an opportunity to review and practice internal procedures and tools to deal with major public health events at the recently inaugurated Emergency Operation centre (EOC). 
Oblikovana je bila tako, da je imel ECDC priložnost, pregledati in vaditi notranje postopke in orodja za obravnavanje pomembnejših dogodkov v zvezi z javnim zdravjem v nedavno odprtem Centru za nujno pomoč (CNP).
In the summer of 2006, a series of outbreaks on cruise ships in European waters, caused by norovirus, led to ECDC’s participation in the outbreak investigation in collaboration with the EU-funded network DIVINE-NET, which is the European network for the prevention of emerging (food-borne) enteric viral infections. 
Poleti leta 2006 je vrsta izbruhov na potniških ladjah v evropskih vodah, ki jih je povzročil norovirus, privedla do sodelovanja centra ECDC pri preiskavi izbruha v sodelovanju z mrežo DIVINE-NET, ki jo financira EU in je evropska mreža za preprečevanje nastajajočih črevesnih virusnih okužb (ki se prenašajo s hrano).
The final results of which were published in the scientific journal Emerging Infectious Diseases. 
Končni rezultati preiskave so bili objavljeni v znanstveni reviji Emerging Infectious Diseases (nastajajoče infekcijske bolezni).
Following the outbreak of Chikungunya in the Indian Ocean in the winter of 2006, ECDC called a consultation of experts in order to assess the short-term risk of transmission of Chikungunya virus in Europe, and to suggest recommendations for the European Member States for strengthening their preparedness. 
Po izbruhu virusa čikungunja v Indijskem oceanu pozimi leta 2006 je ECDC začel posvetovanje, da bi ocenil kratkoročno tveganje prenosa virusa čikungunja v Evropo in predlagal priporočila za izboljšanje pripravljenosti držav članic EU.
- The second one was held in September 2007. 
- drugo posvetovanje je bilo septembra 2007.
See the report 
Glej poročilo;
Professionals in field epidemiology from different EU MS contributed to the online survey organized during summer 2007. 
Strokovnjaki s področja terenske epidemiologije iz različnih držav članic EU so prispevali k spletni anketi, ki je bila pripravljena poleti leta 2007.
The list and its development process were presented to the Advisory Forum in September 2007 and published on 30 January 2008 in a technical document. 
Seznam in postopek njenega oblikovanja sta bila septembra 2007 predstavljena svetovalnemu forumu, objavljena pa 30. januarja 2008 v tehničnem dokumentu.
(see link to institutions in the MS that are CB) 
(glej povezavo do ustanov v državah članicah, ki se štejejo za pristojne organe)
The EPIET Programme Office was gradually incorporated into ECDC, with the integration being completed on November 2007. 
Programska pisarna EPIET se je postopno vključevala v center ECDC, dokončno vključena pa je bila novembra 2007.
The recruitment of fellows enrolled in cohort 14 has been finalized and they have started with the Introductory course in Spain (29 September to 17 October 2008). 
Zaposlovanje strokovnih sodelavcev, vključenih v kohorto 14, je bilo dokončano, in začeli so uvodno usposabljanje v Španiji (od 29. septembra do 17. oktobra 2008).
Corporate publications 
Publikacije ECDC
Past vacancies 
Prejšnje objave prostih delovnih mest
Open calls for tender 
Odprti razpisi za zbiranje ponudb
ECDC Reviews 
Recenzije ECDC
Press review 
Pregled tiska
Preparing guidelines 
Pripravljanje navodil